ANALYST INTERVIEW: DIAGNOSTICS INDUSTRY PROGRESS INVESTMENT HIGHLIGHTS u STEPHEN D. SIMPSON u NORTHLAND SECURITIES.(AAK802) DIAGNOSTICS INDUSTRY PROGRESS INVESTMENT HIGHLIGHTS u STEPHEN D. SIMPSON u NORTHLAND SECURITIES. Reviews the performance of the industry, and examines recent changes that have impacted companies in that sector. Topics discussed include competition, mergers and acquisitions, and the development of customer demand; and a number of companies are identified that are considered well positioned to succeed in the current market. Sector: Biotechnology. Published date 7/13/09. Tickers featured: AZN AZN Asian , BIO, BLUD, CSII CSII Continuous Subcutaneous Insulin Infusion CSII Cancer Surveillance Improvement Initiative CSII Center for Systems Interoperability and Integration , ICUI, ILMN, ISRG ISRG Independent Space Research Group ISRG Independent Safety Review Group , JNJ, LIFE, LMNX, MYGN, PFE, ZOLL. Complete text approximately 3000 words. Document # AAK802. ANALYST INTERVIEWS, The Wall Street Transcript, 67 Wall Street, NY 10005. Voice (212) 952 7433. Fax: (212) 668-9842. E-mail: information@twst.com. |
|
||||||||||||

Printer friendly
Cite/link
Email
Feedback
Reader Opinion